Recent Finacing
Recent Raise
Epiterna is a Swiss biotech that operates a high-throughput platform to evaluate drugs' effects on healthy lifespan, developing translational therapies with planned companion-dog and human clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Epiterna.